(Q43629508)
Statements
Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients (English)
A Seute
R F Schlenk
R Emig
D Wallwiener
E M Grischke
H Döhner
R Haas
1 reference
1 reference